Holen Sie sich die Stockscreener-App
31.25
4.59%
1.37
Handel nachbörslich:
31.27
0.02
+0.06%
Schlusskurs vom Vortag:
$29.88
Offen:
$29.93
24-Stunden-Volumen:
569.30K
Relative Volume:
1.63
Marktkapitalisierung:
$1.32B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+30.78%
1M Leistung:
+40.77%
6M Leistung:
+169.86%
1J Leistung:
+47.16%
1-Tages-Spanne:
$29.88
$31.91
1-Wochen-Bereich:
$24.20
$34.33
52-Wochen-Spanne:
$5.83
$34.33
Zenas Biopharma Inc Stock (ZBIO) Company Profile
Firmenname
Zenas Biopharma Inc
Sektor
Branche
Telefon
857-271-2954
Adresse
852 WINTER STREET, SUITE 250, WALTHAM
Vergleichen Sie ZBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBIO
Zenas Biopharma Inc
|
31.25 | 1.41B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Zenas Biopharma Inc Stock (ZBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-20 | Eingeleitet | Wedbush | Outperform |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-05 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-10-08 | Eingeleitet | Citigroup | Buy |
| 2024-10-08 | Eingeleitet | Guggenheim | Buy |
| 2024-10-08 | Eingeleitet | Jefferies | Buy |
| 2024-10-08 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Zenas Biopharma Inc Aktie (ZBIO) Neueste Nachrichten
How to track smart money flows in Zenas BioPharma Inc.Market Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Multi asset correlation models including Zenas BioPharma Inc.Dollar Strength & Community Driven Trade Alerts - newser.com
What dividend safety score for Zenas BioPharma Inc. stock2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Price momentum metrics for Zenas BioPharma Inc. explainedMarket Weekly Review & Weekly Chart Analysis and Trade Guides - newser.com
How Zenas BioPharma Inc. stock reacts to inflationary pressuresMarket Growth Review & Low Risk Entry Point Tips - newser.com
Applying chart zones and confluence areas to Zenas BioPharma Inc.Day Trade & Daily Profit Maximizing Tips - newser.com
Has Zenas BioPharma Inc. formed a bullish divergenceTrade Analysis Report & Weekly Momentum Picks - newser.com
Is Zenas BioPharma Inc. stock ready for breakoutQuarterly Portfolio Review & High Conviction Trade Alerts - newser.com
Leading vs lagging indicators on Zenas BioPharma Inc. performanceJuly 2025 Outlook & Daily Growth Stock Investment Tips - newser.com
How risky is Zenas BioPharma Inc. stock nowChart Signals & Smart Money Movement Tracker - newser.com
Citigroup Raises Zenas BioPharma (NASDAQ:ZBIO) Price Target to $46.00 - MarketBeat
Zenas BioPharma, Inc.Common Stock (Nasdaq:ZBIO) Stock Quote - FinancialContent
Weiss Ratings Reiterates Sell (E+) Rating for Zenas BioPharma (NASDAQ:ZBIO) - MarketBeat
HC Wainwright Reduces Earnings Estimates for Zenas BioPharma - MarketBeat
Strategies to average down on Zenas BioPharma Inc.Insider Selling & Technical Entry and Exit Tips - newser.com
Published on: 2025-10-31 01:53:58 - newser.com
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7.3%Here's What Happened - MarketBeat
Is Zenas BioPharma Inc a good long term investmentPortfolio Allocation Tips & Free Phenomenal Trading Returns - earlytimes.in
Zenas BioPharma (ZBIO) Price Target Increased by 21.59% to 40.22 - MSN
Promising Phase 2 Results and Strategic Licensing Drive Buy Rating for Zenas BioPharma - TipRanks
Zenas BioPharma (NASDAQ:ZBIO) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
How to build a dashboard for Zenas BioPharma Inc. stockEarnings Recap Summary & Growth Focused Stock Reports - newser.com
Zenas BioPharma (NASDAQ:ZBIO) Given Outperform Rating at Wedbush - MarketBeat
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
HC Wainwright & Co. Maintains Zenas BioPharma (ZBIO) Buy Recommendation - MSN
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap UpWhat's Next? - MarketBeat
1 Trial, 2 Franchises: Zenas Stock Climbs on Landmark Data - sharewise.com
ZBIO: Citigroup Raises Price Target, Maintains Buy Rating | ZBIO Stock News - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out - ACCESS Newswire
ZBIO: Morgan Stanley Raises Price Target, Maintains Overweight R - GuruFocus
Zenas BioPharma, Inc. (ZBIO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Incyte trims pipeline; Zenas surges on MS drug results - BioPharma Dive
ZBIO: HC Wainwright & Co. Raises Price Target, Maintains 'Buy' R - GuruFocus
Zenas’ bifunctional mAb scores at Phase II in relapsing MS - Yahoo Finance
Zenas Biopharma stock reaches all-time high at 29.73 USD By Investing.com - Investing.com Australia
Zenas BioPharma (NASDAQ:ZBIO) Reaches New 12-Month HighTime to Buy? - MarketBeat
Finanzdaten der Zenas Biopharma Inc-Aktie (ZBIO)
Es liegen keine Finanzdaten für Zenas Biopharma Inc (ZBIO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):